The unfolded protein response (UPR) is an endoplasmic reticulum (ER) -related stress conserved pathway that aims to protect cells from being overwhelmed. However, when prolonged, UPR activation converts to a death signal, which relies on its PERKeIF2α branch. Overactivation of the UPR has been implicated in many neurological diseases, including cerebral ischaemia. Here, by using an in vivo thromboembolic model of stroke on transgenic ER stress-reporter mice and neuronal in vitro models of ischaemia, we demonstrate that ischaemic stress leads to the deleterious activation of the PERK branch of the UPR. Moreover, we show that the serine protease tissue-type plasminogen activator (tPA) can bind to cell surface Grp78 (78 kD glucose-regulated protein), leading to a decrease of the PERK pathway activation, thus a decrease of the deleterious factor CHOP, and finally promotes neuroprotection. Altogether, this work highlights a new role and a therapeutic potential of the chaperone protein Grp78 as a membrane receptor of tPA capable to prevent from ER stress overactivation.
The endoplasmic reticulum (ER) stress is a conserved cellular process that activates the unfolded protein response (UPR) that controls the correct functioning of the ER. 1 The UPR combines two responses: an early inhibition of protein synthesis, to avoid protein overload within the ER; and a later upregulation of genes that help protein folding, to clear the ER from native/aberrant proteins. 2 If prolonged, the UPR triggers death signals. 3 Three sensors present at the ER membrane ensure a correct detection of ER stress: IRE1 (inositol-requiring protein-1); ATF6 (activating transcription factor 6); and PERK (protein kinase RNA (PKR)-like ER kinase). IRE1 and ATF6 are normally bound to, and thus inactivated by the ER chaperone Grp78 (78 kDa glucose-related protein, also called Bip for binding immunoglobulin protein). Under stress conditions, Grp78 disengages from IRE1 and ATF6, leading to their activation and the subsequent expression of UPR genes (chaperones, folding and ER proteins). 4 Like the other two sensors, PERK is held inactive by the binding of Grp78. Under stress conditions, PERK phosphorylates its unique substrate, eIF2α (eukaryotic translation initiation factor-2 α-subunit), 5 resulting in a global protein synthesis shutdown. 6 Paradoxically, PERK-mediated eIF2α phosphorylation also activates the transcription of specific genes, including ATF4 (activating transcription factor 4), which triggers a transcriptional programme of stress-responsive genes 7 and of the transcription factor CHOP (C/EBP homologous protein); in case of ER stress overactivation, CHOP will induce death signals. 8 Another target of ATF4 and CHOP, GADD34 (growth arrest and DNA damage-inducible protein 34, a protein phosphatase 1 regulatory subunit), serves as a negative feedback loop by dephosphorylating eIF2α, allowing the recovery of protein translation 4 ( Figure 1a ). These molecular events have been implicated in many neurological diseases, including Alzheimer's disease, Parkinson's disease, Huntington's disease and stroke. 4, 9 Many stroke models are known to activate the UPR. 10, 11 This activation is likely due to the energetic failure and the attendant dysfunctions of calcium pumps, ER-calcium depletion, chaperone dysfunction and the eventual accumulation of misfolded proteins. 4, 12 For example, activation of the PERK branch is evidenced by eIF2α phosphorylation in a model of hypoxia/ischaemia in mice. 13 Moreover, CHOP and GADD34 -the downstream targets of phosphorylated eIF2α (phospho-eIF2α) -are also increased during cerebral ischaemia. [14] [15] [16] [17] In our study, we investigated ER stress-induced neuronal death by using an in vivo model of stroke and two different models of ischaemia/reoxygenation (ex vivo and in vitro). We demonstrate that the PERK branch of the UPR can be controlled by the activation of translocated-ER-resident chaperone Grp78 to the neuronal surface by tissue-type plasminogen activator (tPA). Binding of tPA to Grp78 results in a decrease of PERK/eIF2α activation, and thus a decrease of the deleterious factor CHOP, leading to neuroprotection. For the first time, we describe an active role of cell surface Grp78 signalling in the control of ER stress, thus opening new therapeutic strategies for neurological diseases, especially during stroke.
Results
Thromboembolic ischaemia induces activation of PERK/ATF4 branch of ER stress and is decreased by thrombolysis. CARE-Luciferase mice allow an in vivo detection of the activation of the PERK-eIF2α branch of the UPR 18 ( Figure 1a ). CARE-Luciferase mice were subjected to thromboembolic stroke, induced by the injection of thrombin within the middle cerebral artery. 19 This model allows thrombolysis by recombinant tPA in the same conditions than its use in clinic: a group of mice were thrombolysed with tPA 20 min after stroke induction (10 mg/kg iv; bolus and then infusion over 40 min) while sham group received saline. After 24 h, mice were perfused and brain were harvested to PERK is an ER membrane-bound sensor activated under stress conditions. Once activated, it phosphorylates eIF2α leading to a global shutdown in protein translation. Paradoxically, phosphoeIF2α promotes ATF4 expression and subsequent protein-folding genes to restore ER homeostasis, including GADD34 to restore protein synthesis by dephosphorylating eIF2α. If ER stress is over-activated, ATF4 leads to the expression of CHOP, partially responsible of ER stress-mediated death. (b) Representative cerebral luminescence intensities following sham surgery, thromboembolic ischaemia alone or coupled to thrombolysis with tPA (10 mg/kg IV) (n = 9 for sham animals and n = 10 for ischaemia and ischaemia +tPA). (c) Mean ipsilateral/contralateral hemispheres ex vivo bioluminescence (n = 9 for sham animals and n = 10 for ischaemia and ischaemia+tPA). (d) Mean ipsilateral/ contralateral cortical lysates bioluminescence (data are represented as mean ± S.E.M.; n = 9 for sham animals and n = 10 for ischaemia and ischaemia+tPA). (e) Representative immunostainings against luciferase (green) and NeuN (blue) in the peri-infarct area. (*Po0.05, **Po0.01, ***Po0.001; Mann-Whitney test; scale bar, 20 μm) measure ex vivo luciferase activity in the ischaemic (ipsilateral) and contralateral hemispheres. As shown on the images and on the quantifications (Figure 1b and c), ischaemic stroke increased by 2.4-fold the bioluminescent signal compared to sham conditions (ipsi/contralateral hemispheres) (n = 9, Po0.001). Thrombolysis with tPA reduced by 46% ischaemia-induced luciferase signal (n = 9; Po0.01). Concordant with the ex vivo findings, in vitro luciferase assays ( Figure 1d ) showed a strong ischaemia-induced luciferase activity (+270% versus sham mice; n = 9; Po0.01) that was reduced by tPA-induced thrombolysis (56% reduction compared to ischaemia alone; n = 9, Po0.01). Immunostainings against luciferase also highlighted in the peri-infarct cortical region a strong ischaemia-induced labelling which was reduced by thrombolysis ( Figure 1e ). However, because tPA can positively or negatively control neuronal survival through multiple pathways 20, 21 in addition to its thrombolytic effects, we wondered if the decrease of ER stress observed after thrombolysis was only due to its vascular properties or not.
OGD/reoxygenation induces a deleterious activation of the PERK branch of ER stress that is counteracted by tPA. tPA is now considered as a neuromodulator. 20, 22 Because it is complicated to decipher its parenchymal roles from its thrombolytic action, we decided to use a model of ischaemia where thrombolysis is not necessary: an ex vivo model of hippocampal slices subjected to 40 min of OGD followed by reoxygenation (OGD reox ) (Figure 2a ). To ensure ER stress activation, we measured the level of eIF2α phosphorylation by western blots 24 h after the experiment. When compared to control, OGD reox led to an increase of eIF2α phosphorylation (Figure 2b and quantification in Figure 2c , 2.5-fold increase, Po0.01), confirming the activation of ER stress. Interestingly, tPA prevented OGD reoxmediated eIF2α phosphorylation (Figure 2d and quantification in Figure 2c , n = 6, Po0.05) independently from its thrombolytic properties. We also assessed cell death, by propidium iodide staining ( Figure 2d ) and as observed in vivo after ischaemic stroke, tPA protected from OGD reox -induced cell death (Figure 2e , 60% of protection, n = 5, Po0.01). Taken together, these results show that during OGD reox , tPA reduces the activation of the PERK-eIF2α branch of the UPR independently of its thrombolytic activity.
OGD/reoxygentation overactivates the PERK branch of ER stress in pure cortical neurones and is decreased by tPA. To study the mechanism of action of tPA, we next used cultures of pure cortical neurones subjected to OGD reox (Figure 3a) . In these conditions, the PERK-eIF2α branch was activated, as illustrated by immunostainings against phospho-eIF2α (Figure 3b ). ER stress activation increased as a function of the duration of OGD, as shown by the extent of eIF2α phosphorylation ratio compared to the total form, after various time of OGD and followed by 4 h of reoxygenation ( Figure 3c and densitometries in Figure 3d , 1.84-, 2.68-and 3.86-fold increase of eIF2α phosphorylation at 10, 40 and 60 min of OGD, respectively, Po0.05). In this neuronal model, tPA 300 nM also prevented the activation of the PERK branch as illustrated by immunostainings (Figure 3b ) and immunoblots against phospho-eIF2α (Figure 3c and densitometries in Figure 3d , tPA reduces by 44%, 46% and 40% the phosphorylation of eIF2α after 10, 40 and 60 min of OGD reox , respectively, Po0.05). We also studied by qPCR the transcriptional downstream targets of phospho-eIF2α ( Figure 1a) . OGD reox increased mRNA levels of ATF4, CHOP, GADD34 and Grp78 (Figure 3e ) by 2-, 1.6-, 1.54-and 1.6-fold, respectively. This ER stress activation measured by qPCR was totally prevented in the presence of tPA, except for Grp78 (Figure 3e) . In parallel to these evidence of timedependent activation of the PERK-eIF2α branch, we also found that OGD reox induced a neuronal death of which the extent increased with the duration of OGD (Supplementary Figure 1 ; Spearman correlation test: ρ = 0.777; Po0.0001) and that was correlated to the levels of phospho-eIF2α (Spearman correlation test: ρ = 0.671; P = 0.026). Co-treatment with tPA (300 nM) reduced by 38% the extent of neuronal loss induced by OGD reox (40 min OGD followed by 4 h reoxygenation; Figure 3f , Po0.01), showing a neuroprotective action of tPA via an alleviation of the recruitment of the PERK branch of the UPR in ischaemic neurones.
The neuronal ER continuity is preserved under OGD/ reoxygenation in the presence of tPA. ER dysfunction is often associated to ER swelling and fragmentation. To visualize the neuronal ER continuity/integrity in our experimental conditions, we performed live imaging of neurones with the cell-permeant dye ER tracker (Figure 4 ). Due to the use of glass bottom Petri dishes for the confocal acquisition, neurones need the presence of astrocytes to attach to the glass bottom part; we then adapted the protocol of OGD reox to 1 h of OGD, in order to obtain the same level of cell death than 40 min OGD on pure cortical neurones. Z-stack acquisitions were performed to enable a 3D reconstruction by Imaris Software (Bitplane; Concord, MA, USA) (representative reconstruction Figure 4a , blue images). In control conditions (with or without 300 nm tPA), the ER continuity was preserved with an ER surrounding the nucleus and projecting in neurites (Figure 4a ). However, after OGD reox the ER continuity was lost, with an apparent swelling and an ER fragmentation ( Figure 4a , blue images). When tPA was added during the OGD reox , ER continuity was preserved. Neuronal swelling was estimated by measuring the somatic diameter of neurones (10 per condition, in five distinct microscopic fields; each individual neurones was recorded every hour) after staining with the ER tracker as illustrated on the images at 4 h (Figure 4a , green images). Under control conditions, tPA 300 nM alone did not modify the neuronal body diameter, while OGD reox led to a 1.5-, 1.8-, 2.11-, 2.26-and 2.34-fold increase of neuronal body diameter at t0, t1, t2, t3 and t4 respectively, ***Po0.001 compared to control). When tPA is added during OGDreox, the neuronal body diameter increased over time (Figure 4b, 1.05-, 1.1-, 1.16-and 1.18-fold at to, t1, t2, t3 and t4 respectively; **Po0.01, ***Po0.001 compared to control) but less than under OGD reox alone (Figure 4b , 31%, 29%, 22%, 23% less than OGD reox at to, t1, t2, t3 and t4, respectively; Po0.001 compared to OGD reox alone). It demonstrates that tPA is able to maintain ER continuity and the neuronal morphology under OGD reox .
tPA decreases the PERK-eIF2α branch of the UPR by a mechanism dependent on its lysine-binding site. We then investigated the mechanisms by which tPA decreases the PERK branch of ER stress and death under OGD reox . We first used a proteolytically inactive form of tPA (itPA: tPAdGGACK; 300 nM) and showed that despite its lack of enzymatic activity, itPA remained able to confer neuroprotection ( Figure 5a , 19% of neuronal death for itPA under OGD reox ; 50% for OGD reox alone; and 31% for tPA and OGD reox , Po0.001). The growth factor domain of tPA confers antiapoptotic capacity through its binding to the EGF receptor. 23, 24 However, AG1478 (5 μM), an EGFR tyrosine kinase inhibitor, did not prevent the beneficial effect of tPA during OGD reox ( Figure 5b , 31% of neuronal death for tPA under OGD reox ; 26% for tPA+AG1478 under OGD reox ), excluding a role for EGF receptor. tPA can also interact through its finger domain with LRP-1 (type 1 low-density lipoprotein receptor-related protein) to promote NFκB activation 25 and Akt phosphorylation. 26 The addition of RAP In order to compete with the binding of its LBS, we used the lysine analogue TXA (tranexamic acid) at the same concentration than tPA (300 nM). Interestingly, TXA reversed the protective effect of tPA during OGD reox ( Figure 5d , 27% of neuronal death for tPA under OGD reox ; 41% for tPA+TXA under OGD reox , Po0.05), suggesting a role for the LBS contained within the Kringle 2 domain of tPA to mediate its action on neuroprotection during OGD reox .
OGD/reoxygenation promotes cell surface Grp78, and its activation induces a beneficial decrease of ER stress. It is now well accepted that under ER stress conditions, the ER-resident chaperone Grp78 translocates to the cell surface. 27, 28 To confirm this in our OGD reox conditions, we biotinylated membrane proteins before and after 40 min of OGD, and we performed an avidin pull-down followed by a western blotting against Grp78. We show an increase of cell surface Grp78 after OGD compared to control (Figure 6a ), in favour of a translocation of Grp78 to the neuronal membrane.
We then checked the ability of tPA to be a cell surface Grp78 ligand. Immunoprecipitations (IP) were performed with both Grp78 and tPA antibodies on neurones subjected to OGD reox and treated or not with 300 nM of tPA (Figure 6b ). The pulldown with Grp78 antibodies revealed a Grp78 band by western blot as a positive control, and the tPA pull-down also revealed a Grp78 band (Figure 6b) , confirming tPA as a ligand. Indeed, the interaction between tPA and cell surface Grp78 has been reported in neuroblastoma cells. 29 The binding of tPA to Grp78 occurs on the amino acid sequence 98-115 (LIGRTWNDPSVQQDIKFL). 29 We thus synthetized a corresponding competitive peptide called Grp78 (98) (99) (100) (101) (102) (103) (104) (105) (106) (107) (108) (109) (110) (111) (112) (113) (114) (115) , and confirmed its competitive nature in a plasminogen-like fluorogenic substrate assay. Recombinant Grp78 7.3 pM (equimolar to tPA concentration) or 10 times concentrated increased tPA fibrinolytic activity by 25 and 40% respectively (Supplementary Figure 2A, Po0.001) . Interestingly, a tPA mutated in its LBS contained within the kringle 2 domain (tPA K2*: W253R mutation) is no longer able to interact with Grp78, as shown by the absence of increased tPA K2* activity (Supplementary Figure 2B) . When co-incubated with Grp78 (98-115) (7.3 or 73pM), Grp78 could no longer potentiate tPA fibrinolytic activity (Supplementary Figure 2A) . A scramble peptide Grp78 (98-115)sc had no action on the potentiation of tPA fibrinolytic activity by Grp78 ( Supplementary  Figure 2A; Po0.01). We then ensured the capacity of Grp78 (98) (99) (100) (101) (102) (103) (104) (105) (106) (107) (108) (109) (110) (111) (112) (113) (114) (115) to decrease the binding of tPA to cell surface Grp78 in living neurones. 35 S radiolabelled tPA (tPA*) was incubated on neurones after 40 min of OGD in the presence or not of Grp78 (98-115) (10 μM) during 30 min at 4°C (to avoid any active process of internalization). Our data demonstrate a decrease of tPA* at the neuronal membrane in the presence of Grp78 (98) (99) (100) (101) (102) (103) (104) (105) (106) (107) (108) (109) (110) (111) (112) (113) (114) (115) (Figure 6c , 49.2% decreased with Grp78 (98-115) ; Po0.001), confirming the ability of our peptide to decrease the binding between tPA and cell surface Grp78 in neurones. We then tested the blocking peptide under OGD reox conditions. After 40 min of OGD and 4 h of reoxygenation, Grp78 (98-115) reversed tPA-mediated inhibition of the PERK branch, as shown by western blot against eIF2α phosphorylation (Figure 6d ) and the corresponding densitometries (Figure 6e ; ratio of 1.02 between the phosphorylated and the total form of eIF2α for tPA under OGD reox ; 1.52 for tPA +Grp78 (98) (99) (100) (101) (102) (103) (104) (105) (106) (107) (108) (109) (110) (111) (112) (113) (114) (115) under OGD reox ; Po0.05). Interestingly, Grp78 (98) (99) (100) (101) (102) (103) (104) (105) (106) (107) (108) (109) (110) (111) (112) (113) (114) (115) totally reversed the neuroprotective effect of tPA in cortical neurones (Figure 6f , 31% of neuronal death for tPA+Grp78 (98) (99) (100) (101) (102) (103) (104) (105) (106) (107) (108) (109) (110) (111) (112) (113) (114) (115) under OGD reox , 12% for tPA under OGD reox ; Po0.01). To ensure our findings, we also tried the peptide on hippocampal slices subjected to OGD reox . Grp78 (98-115) also reversed tPA-mediated inhibition of the PERK branch as shown by western blot against eIF2α phosphorylation ( Figure 6g and the densitometries Figure 6h ; ratio of 1.02 between the phosphorylated and the total form of eIF2α for tPA under OGD reox ; 1.52 for tPA+Grp78 (98) (99) (100) (101) (102) (103) (104) (105) (106) (107) (108) (109) (110) (111) (112) (113) (114) (115) under OGD reox ; Po0.05). Grp78 (98) (99) (100) (101) (102) (103) (104) (105) (106) (107) (108) (109) (110) (111) (112) (113) (114) (115) also prevented the protection by tPA on hippocampal slices subjected to OGD reox (Figure 6i , 61% of protection for tPA under OGD reox , Neuronal death assessed by LDH release in the media after 40 min of OGD followed by 4 h of reoxygenation in the presence or not of 300 nM tPA, or in the presence of inactive tPA (itPA) 300 nM. tPA was also tested in addition to AG1478 5 μM (b), RAP (500 nM) (c) and TXA 300 nM (d), (data are represented as mean ± S.E.M. n = 30 for ctrl, n = 28 for OGD, n = 32 for tPA, n = 22 for itPA, n = 18 for AG1478, n = 12 for RAP, n = 16 for TXA; from four independent experiments; *Po0.05; **Po0.01; ***Po0.001; Mann-Whitney test)
Cell surface Grp78 decreases ER stress M Louessard et al totally reversed with the co-application of Grp78 (98-115) , **Po0.01). Again, this effect was associated with a reversion of the inhibition of eIF2α phosphorylation by tPA (Figure 6g and h, ratio of 1.34 between the phosphorylated and the total form of eIF2α for tPA under OGD reox , 2.55 for tPA+Grp78 (98) (99) (100) (101) (102) (103) (104) (105) (106) (107) (108) (109) (110) (111) (112) (113) (114) (115) under OGD reox ; Po0.05). Taken together, these data show that modulating cell surface Grp78 during intense ER stress is a new and interesting therapeutic target to prevent cell death from deleterious ER stress.
Discussion
In this study, we demonstrate for the first time that the binding of tPA to cell surface Grp78, triggers a signal that decreases detrimental ER stress overactivation in neurones, resulting in neuroprotection. We also show that ischaemic events lead to the translocation of the chaperone Grp78 from the ER to the neuronal surface, a mechanism described under ER stress activation and in cancer. 27, 28 Interestingly, the serine protease tPA is able to bind to cell surface Grp78 leading to a decrease of the PERK/eIF2α axis of the UPR, and resulting in neuronal survey during cerebral ischaemia. To study ER stress activation, we first subjected CAREluciferase mice to thromboembolic ischaemia, alone or coupled to reperfusion by tPA in the same conditions than its clinical use. 19 We observed a strong activation of the eIF2α-ATF4 pathway after ischaemic stroke, a surrogate marker of the activation of the PERK-eIF2α branch of the UPR. Indeed, while kinases other than PERK can phosphorylate eIF2α (GCN2 (general control nonderepressible 2), HRI (haemregulated eIF2α kinase) and PKR (Protein kinase RNAactivated), studies in genetically deficient mice revealed that during cerebral ischaemia, PERK is the only kinase responsible for eIF2α phosphorylation. 30, 31 We also demonstrated an increase of cell surface Grp78 at the neuronal surface after OGD reox (Figure 6a ). Grp78 is mostly known as an ER chaperone, belonging to the heatshock protein family, but it has also been described at the cell Figure 6 The interaction between tPA and cell surface Grp78 is responsible of the decrease of the PERK branch activation and the associated neuroprotection during OGD reox . (a) Avidin pull-down and western blot against Grp78 on neurones subjected or not to 40 min of OGD, followed by the biotinylation of membrane protein at 4°C (representative blot from n = 3 independent experiments). (b) Immunoprecipitations with either Grp78 or tPA antibodies on neurones subjected to 40 min of OGD, and revealed by western blot against Grp78 (representative blot of three independent experiments). (c) Membrane-bound radioactivity after radioactive tPA (tPA*) incubation (30 min) at 4°C following a 40 min OGD period in presence or not of 10 μM of Grp78 (98) (99) (100) (101) (102) (103) (104) (105) (106) (107) (108) (109) (110) (111) (112) (113) (114) (115) peptide (data are represented as mean ImmunoprecipitatioSEM n = 4 independent experiments; ***Po0.001 Mann-Whitney test). (d) Representative western blots against phosphor-and total eIF2α and corresponding densitometries (e) from pure cortical neurones subjected to 40 min of OGD followed by 4 h of reoxygenation, in the presence or not of 300 nM tPA and 10 μM Grp78 (98-115) (data are represented as mean ± S.E.M. n = 5 independent experiments; *Po0.05 compared to normoxia; £ Po0.05 compared between OGD reox conditions). (f) Neuronal death of pure cortical neurones assessed by LDH release after 40 min of OGD followed by 4 h of reoxygenation in the presence or not of 300 nM tPA and 10 μM Grp78 (98-115) (data are represented as mean ± S.E.M. n = 25 for ctrl, n = 20 for OGD reox , n = 16 for tPA, tPA+Grp78 (98) (99) (100) (101) (102) (103) (104) (105) (106) (107) (108) (109) (110) (111) (112) (113) (114) (115) and Grp78 (98) (99) (100) (101) (102) (103) (104) (105) (106) (107) (108) (109) (110) (111) (112) (113) (114) (115) from five independent experiments; *Po0.05; **Po0.01; ***Po0.001; Mann-Whitney test). (g) Representative western blots against phospho-and total eIF2α on hippocampal slices subjected to 40 min of OGD followed by 24 h of reoxygenation, in the presence or not of 300 nM tPA and 10 μM Grp78 (98) (99) (100) (101) (102) (103) (104) (105) (106) (107) (108) (109) (110) (111) (112) (113) (114) (115) and corresponding ratio of the phosphorylated versus total form of eIF2α (H) (data are represented as mean ± S.E.M. n = 6; *Po0.05; **Po0.01; Mann-Whitney test). (i) Cell death assessed by counting of propidium iodide-positive cells in slices 24 h after treatments and normalized to the OGD reox condition in the presence or not of 300 nM tPA and 10 μM Grp78 (98) (99) (100) (101) (102) (103) (104) (105) (106) (107) (108) (109) (110) (111) (112) (113) (114) (115) (data are represented as mean ± S.E.M. n = 12 from four independent experiments; *Po0.05, **Po0.01, ***Po0.001, Mann-Whitney test)
surface of cancer cells, 29, 32 macrophages, 27 endothelial cells, 33, 34 and cardiomyocytes. 32 Accordingly, Grp78 is now recognized as a receptor/co-receptor for different partners, including activated α2-macroglobulin, 35 plasminogen/ microplasminogen, 36 some viruses, 37,38 major histocompatibility complex class I 38 and voltage-dependent anion channels. 36 Grp78 has also been shown to interact with tPA, resulting in an increase in plasmin formation. 29 Here, we demonstrate the presence of cell surface Grp78 in neurones, and we confirm the occurrence of the interaction between Grp78 and recombinant tPA (Figure 6b ), but extend its functional impact to neuroprotection. To our knowledge, Grp78 has no intrinsic ability to convey intracellular signals, as demonstrated by analyses of its sequence and hydropathicity. 27 Rather, Grp78 would need co-receptors. 27 In our study, none of the classical neuronal receptors of tPA (NMDA receptor, LRP1, EGFR) seem to be involved in the effect observed ( Figure 5 ). Hypoxia/ischaemia 39 or ER stress 28, 32 are known triggers of Grp78 translocation. However, how Grp78 translocates from the ER to the cell membrane remains unclear. In 293 T cells, thapsigargin treatment leads to a 12-fold increase of cell surface Grp78 that is different from its increase within the ER, 32 suggesting that ER stress promotes specific mechanism(s) to enhance cell surface localization of Grp78. Importantly, Grp78 is brought to the cell surface by a specific mechanism, as extracellular Grp78 originating from dead cells cannot stably attach to the cell surface. 32 In addition, a same signal induces or not Grp78 translocation in different cells. For instance, hypoxia enhances Grp78 at the membrane of neurones but not of astrocytes. 39 Our study also describes a new role for the serine protease tPA. It remains the gold standard treatment for cerebral ischaemia despite its short therapeutic window. 40, 41 But since several years, it is clearly admitted that tPA is more than a vascular enzyme with many roles in the cerebral physio pathology. 20 tPA has first been described as a pro-excitotoxic protein, 42 mainly by interacting with the GluN1 subunit of the NMDA receptor. 43 In the meantime, it has also been shown that cerebral tPA was anti-apoptotic. 44 Things seem more complex, as depending of its form, its dose, and its localization tPA can display pro-survival effects on neurones. 21, 45 For example, tPA is neuroprotective in a model of glucose privation 46 and a model of cerebral ischaemia, 47 and this effect required NMDA receptors. At the first look, it could seem contradictory with previous findings where tPA interaction with NMDA receptors was detrimental in stroke. 43, 48 But in fact it seems that protective effects of tPA are mediated by the activation of synaptic NMDA receptors, 47 while its activation of extrasynaptic receptors leads to excitotoxicity. 49 Here, we identified cell surface Grp78 as a new neuronal receptor of tPA. It's binding leads to negative feedback on the PERK branch activation, resulting in less eIF2α phosphorylation, and more importantly less CHOP induction, so less death during ischaemic events. Importance of Grp78 is confirmed by studies using AdoPep1, a peptide identified in the metalloproteinase domain of a disintegrin and metalloproteinase 15 protein (ADAM15), that binds to cell surface Grp78 and inhibits hypoxia-induced apoptosis in endothelial cells and increases Akt phosphorylation and ERK 1/2 activation. 34 Moreover, AdoPep1 also inhibits hypoxia-induced apoptosis in cardiomyocytes and protects cardiac cells during myocardial ischaemia, 50 and also prevents pancreatic β-cells from type 1 diabetes-induced apoptosis. 51 Another compound, BIX (BiP Inducer X), is able to induce the expression of Grp78 through the ATF6 pathway. 52 BIX has been shown to protect neuroblastoma cells from ER stress-induced cell death and to decrease infarct size in rodents following various models of cerebral ischaemia. 52, 53 However, none of these studies have investigated the precise localization of the protein.
Overall, we describe here for the first time a PERK-eIF2α-negative feedback due to the activation of cell surface Grp78 by the serine protease tPA. We confirm the translocation of Grp78 from the ER to the neuronal surface, and we validate tPA as a ligand of Grp78. We demonstrate that tPA activation of cell surface Grp78 is capable to mediate beneficial effects on ER stress during cerebral ischaemia independently of its thrombolytic activity. Taken altogether, Grp78 represents an original therapeutic target to decrease the deleterious effects associated to ER stress. Experiments were performed following the ARRIVE guidelines (www.nc3rs.org.uk), including randomization and blind analyses. Mice were deeply anaesthetised with 5% isoflurane (Baxter, Paris, France, in a mixture of N 2 O/O 2 ), placed in a stereotaxic device and maintained under anaesthesia for up to 2 h with 2% isoflurane in a 70/30 mixture of N 2 O/O 2 . Through a skin incision between the right eye and ear, the masseter muscle was excised, and a small craniotomy (diameter 1 mm) was performed on the parietal bone to expose the right middle cerebral artery. Thromboembolic stroke was induced as previously described. 19 Briefly, craniotomy was performed by using cooled drill, then the dura was excised and a pipette filled with murine thrombin (1 UI/μL) was directly inserted in the MCA lumen. One microliter of thrombin was injected to induce thrombus formation. Thrombolysis was induced by intravenous tPA (actilyse 10 mg/kg) administration (10% bolus, 90% over 40 min) 20 min after clot onset. Control animals received intravenous saline injection in the same conditions, and sham animals only had the surgical approach.
Bioluminescence imaging. CARE-Luciferase mice expressing the luciferase reporter gene under the control of the thymidine kinase promoter activated by two Trb3 (tribbles pseudokinase 3) sequences containing the three CARE (C/EBP (CCAAT/enhancer binding protein)-ATF response element) sequences of recognition (black circles on Supplementary Figure 3A) were previously described. 18 Control experiments were performed after a local injection of tunicamycin (a well-known inducer of ER stress, 0.05 μg/g) in their abdomen. As expected, the luciferase signal measured 6 h after the injection of tunicamycin was increased by 20-fold when compared to control non-injected mice (representative images Supplementary Figure 3B and corresponding means Supplementary Figure 3C ; n = 6; Po0.01).
Post-stroke bioluminescence imaging was performed using the IVIS Spectrum (PerkinElmer, Villebon-sur-Yvette, France) imaging scanner coupled to the Living Image Software (PerkinElmer). Briefly, 100 mg/kg of in vivo luciferase substrate (beetle luciferin substrate, Promega) were injected intraperitoneally into each CARELuciferase mouse. Mice were then anaesthetised with isofluorane-and scanned 10 min after luciferin injection. The abdominal cavity was shaved to allow accurate collection of bioluminescence signals. Light emission was quantified with imaging software from constant regions of interest (ROI) drawn manually. Photon emission was measured as radiance in ps-1cm-2sr-1. The sensitivity of the imaging scanner was tested weekly with commercially available positive sources of bioluminescence. Excised brains were imaged immediately after euthanasia using the IVIS Spectrum (PerkinElmer) imaging scanner coupled to the Living Image software (PerkinElmer).
Luciferase biochemical assay. Luciferase assays were performed as previously described. 54 Luciferase activities measured in brain extracts were normalized to protein content (RLU/mg protein) and expressed as fold induction relative to the control condition.
Organotypic hippocampal slice cultures. Seven-day-old mouse pups of either sex were decapitated and their brain collected in PBS containing 5 mg of glucose. Hippocampal slices (400 μm) were prepared using a McIlwain tissue chopper (Brinkmann Instruments, World Precision Instruments, Hitchin, UK) and placed on 0.4 μm Millicell culture inserts (Millipore, Guyancourt, France), as previously described. 24 Slices were maintained in a humidified incubator with 5% CO 2 at 37°C with 1 ml of MEM containing 20% horse serum, supplemented with 10 mM HEPES and insulin, pH 7.2-7.3.
Neuronal cell cultures. Primary cultures of cortical neurones were prepared from foetal mice (embryonic day 14) as previously described. 55 Cells were cultured on individual glass bottom Petri dishes (MatTek Corporation, Ashland, MA, USA) or 24-well plates, previously coated with poly-D-lysine (0.1 mg/ml) and laminin (0.02 mg/ml), in DMEM supplemented with 5% foetal bovine serum, 5% horse serum and 1 mM glutamine. Cultures were maintained at 37°C in a humidified 5% CO2 atmosphere. Cytosine β-D-arabinoside (10 μM) was added after 3 days in vitro (DIV) to inhibit glial proliferation in the 24-well plates. Oxygen and glucose deprivation was performed after 11-12 DIV.
Oxygen and glucose deprivation (OGD). Hippocampal slices (7 DIV) or neuronal cultures (11-12 DIV) were subjected for various times to OGD in a hypoxic chamber (IN VIVO2 500; Ruskinn, AWEL International, Blain, France) programmed at 1% O 2 , 5% CO 2 and 37°C in glucose/serum-free deoxygenated DMEM. For reoxygenation, media were switched to oxygenated DMEM completed with D-glucose (4.5 mg/l) under normoxic conditions. Controls were subjected to sham washes.
Neuronal death. For hippocampal slices, neuronal death was assessed 24 h after reoxygenation by propidium iodide fluorescence. Propidium iodide (50 μg/μl) was added for 30 min in the medium, washed in PBS and then immersed in fixative buffer during 1 h (4% of paraformaldehyde in 0.1 M PBS, pH 7.4). Images were digitally captured using a Leica SP5 confocal microscope (Leica Microsystems SAS, Nanterre, France) and visualized with LAS AF lite software (Leica) and further quantified using ImageJ 1.45r software (National Institute of Health, Bethesda, MD, USA).
For cortical neurones, neuronal death was quantified 4 h after reoxygenation by measuring the lactate dehydrogenase activity released from damaged cells into the bathing medium with a cytotoxicity detection kit (Roche Diagnostics, Meylan, France).
Immunoblotting. Cells were dissociated in ice-cold TNT buffer (50 mM TrisHCl pH 7.4; 150 mM NaCl; 0.5% Triton X-100; phosphatase and protease inhibitors cocktails) and centrifuged (12,000 g, 4°C, 15 min). Protein concentration was measured by BCA Protein Assay method. Proteins (20 μg) were resolved on a 10% SDS-PAGE gel (Bio-rad, Marnes-la-Coquette, France) and transferred onto a polyvinylidene difluoride membrane. Membranes were blocked with PBS+0.1% tween-20, 5% milk and incubated overnight at 4°C in blocking buffer containing primary antibodies. The following primary antibodies and dilutions were used: mouse anti-eIf2α (1/1000; Cell Signaling L57A5; Ozyme, Montigny-le-Bretonneux France), rabbit anti-Phospho-eIf2α (1/1000 Cell Signaling 119A11), goat anti-tPA (1/1000; sc5239; Santa-Cruz, Heidelberg, Germany). Membranes were then incubated with the corresponding peroxidase-conjugated secondary antibodies (1/25000; Sigma-Aldrich) in blocking buffer, and visualized with an enhanced chemiluminescence Pierce ECL Plus kit.
Quantitative real-time PCR. Total RNA was isolated from neuronal culture with TRI reagent according to the manufacturer instructions. Total RNA was treated with TURBO DNase (Ambion, Saint Aubin, France) to avoid DNA contamination and quantified by spectrophotometry (NanoDrop Technologies, Wilmington, DE, USA). One μg of total RNA was reverse-transcribed by using the M-MLV Reverse transcriptase according to the manufacturer's instructions with the following cycle conditions: 42°C (90 min); 85°C (5 min). RT-qPCR was performed from 1:20 diluted cDNA in iQ SYBR Green Supermix (Bio-Rad; Marnes-la-Coquette, France) containing 500 nM of each primer. Based on mRNA-coding sequences (www. ensembl.org), mouse-specific primers were designed by using the Primer3Plus software (http://www.bioinformatics.nl/cgi-bin/primer3plus/ primer3plus.cgi) 56 (sequences are in Table 1 ). Assays were run in triplicate on the CFX96 real-time system c1000 thermal cycler (Bio-Rad), with the following cycle conditions: 95°C (3 min); (95°C (2 s), 60°C (20 s)) × 39; 70°C (30 s). Normalization was performed according to the results of the geNorm analysis (QBase+ software, Biogazelle, Zwijnaarde, Belgium) (Supplementary Figure 4) as previously described.
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Immunohistochemistry. Twenty-four hours after ischaemia mice were deeply anaesthetised and transcardially perfused with 0.9% NaCl heparinized followed by a mixture of 4% paraformaldehyde in 0.1 M PBS, pH 7.4 (150 ml). Brains were removed, washed in PBS buffer containing 20% sucrose and frozen in Tissue-Tek (Miles Scientific, Naperville, IL, USA). Coronal sections (10 μm) were cut on a cryostat (Leica CM3050, Leica Microsystems SAS), collected on poly-Dlysine slides, and stored at − 80°C. Sections were incubated overnight at room temperature with a goat anti-luciferase antibody (1/200; ab81823, Abcam, Cambridge, UK). The secondary F(ab')2 coupled to fluorescein isothiocyanate (FITC; 1:600; Jackson ImmunoResearch, West Grove, PA, USA) was used for visualization under epifluorescence. Washed sections were coverslipped with ) (Grp78 (98) (99) (100) (101) (102) (103) (104) (105) (106) (107) (108) (109) (110) (111) (112) (113) (114) (115) ; LIGRTWNDPSVQG-DIKFL) and scramble (Grp78 (98-115)sc ; GTNKSQDLWIPQLRDVFI) peptides were synthesized (0.1 mmol scale) on Fmoc-Leu-HMP and Fmoc-Ile-HMP resins, respectively, using an Applied Biosystems model 433A automatic peptide synthesizer (Life Technologies; Villebon-sur-Yvette, France) and the standard procedures, as previously described. 58, 59 All Fmoc-amino acids (1 mmol, 10 eq.) were coupled by in situ activation with HBTU (1.25 mmol, 12.5 eq.) and DIEA (2.5 mmol, 25 eq.) in NMP. Reactive side-chains were protected as follows: Arg, pentamethyldihydrobenzofuran (Pbf) sulfonylamide; Asn and Gln, trityl (Trt) amide; Ser, Thr and Tyr, tert-butyl (tBu) ether; Asp and Glu, O-tert-butyl (OtBu) ester; Lys and Trp, tert-butyloxycarbonyl (Boc) carbamate. Peptides were deprotected and cleaved from the resin by trifluoroacetic acid (TFA) as previously described. 60 Crude peptides were purified by reversed-phase HPLC (RP-HPLC) on a Vydac 218TP1022 C18 column (2.2 × 25 cm; Grace Discovery Sciences Alltech, Templemars, France) using a linear gradient (10-60% over 60 min for Grp78 (98- 
